PATENT CLAIM ANALYSIS

Application Number: 15928509
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
A pharmaceutical preparation and method for treating connective tissue damage in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of a glycosaminoglycan composition comprising chondroitin sulfate, hyaluronan, and N-acetyl D-glucosamine, wherein the connective tissue is skin.

Claim (Index 20):
The method of  claim 19 , wherein the therapeutic agent is selected from the group consisting of a synthetic or a non-synthetic corticosteroid agent, nonsteroidal anti-inflammatory agent, antirheumatic agent, immunoregulatory agent, immunosuppressant agent, articular function augmentory agent, interleukin production inhibitor, growth factor, and a tissue or a stem cell having a therapeutic effect.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13545327', '14941754', '14511274', '11766510', '13891979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.850257484513181
- 35 USC 102 Novelty (BERT): 0.5688321137393715
- Combined Prediction Score: 0.8221149474358
- Mean Citation Score: 432.1815
- Max Citation Score: 451.97458
- Similarity Product: 432.0258313731409

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test